Company intelligence / Profile preview

NeuroView

Yokneam, Israel

Ownership: Private
Development stage: Other

Overview

NeuroView was an Israel-based medical technology company focused on developing non-invasive brain monitoring systems for the early detection of stroke. The company's primary technology was designed to provide real-time monitoring of brain activity to identify neurological changes associated with ischemic events. By enabling earlier intervention, NeuroView aimed to improve clinical outcomes and reduce the long-term disability associated with stroke. The company was acquired by Medtronic in 2008 to bolster its neurological monitoring portfolio.

Therapeutic areas: Neurology
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on NeuroView.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroView.

Explore the full profile